Publications by authors named "Japinder Kaur"
Article Synopsis
- Elevated lipoprotein(a) [Lp(a)] is a significant genetic risk factor for atherosclerotic cardiovascular disease (ASCVD), increasing the risk by 2-4 times, which is particularly concerning in patients undergoing secondary prevention.
- A systematic literature review was conducted to analyze studies from 2010 to 2022 that assessed the clinical impact of elevated Lp(a) levels, resulting in 61 studies, with 26 specifically addressing the burden of elevated levels on health outcomes.
- Key findings indicated that elevated Lp(a) levels are linked to a higher risk of major cardiovascular events, myocardial infarction, and cognitive impairments, showcasing a negative effect on patients' health-related quality of life, although meta-analysis was hindered by
